Dems want to unmask Eli Lilly's obesity drug user, a new genome-editing tool raises ethics questions, and more health news
| # | Наименование новости | Тональность | Информативность | Дата публикации |
|---|---|---|---|---|
| 1 | STAT+: Embryo editing advances reignite ethical debates | 0 | 5 | 26-06-2026 |
| 2 | Supreme Court ruling blocks thousands of lawsuits against maker of Roundup weedkiller | 0 | 7 | 25-06-2026 |
| 3 | STAT+: Democrats press White House on who got special access to Eli Lilly’s new obesity drug | 0 | 7 | 25-06-2026 |
| 4 | STAT+: Roche ends Huntington’s gene-silencing programs | 0 | 5 | 10-07-2026 |
| 5 | The mysterious case of Eli Lilly’s obesity drug | 0 | 5 | 25-06-2026 |
| 6 | STAT+: Pharmalittle: We’re reading about a court win for Amgen, Novo seeking supplier discounts, and more | 0 | 5 | 02-07-2026 |
| 7 | Supreme Court: Drug users can own guns, casting doubt on Hunter Biden case | 0 | 9.81 | 20-06-2026 |
| 8 | STAT+: Lawmakers urge HHS to force Eli Lilly to provide 340B drug discounts to hospitals | 0 | 5 | 02-07-2026 |
| 9 | Supreme Court ruling blocks thousands of lawsuits against maker of Roundup weedkiller | 0 | 7 | 28-06-2026 |
| 10 | STAT+: Next-gen CRISPR tools improve editing accuracy in embryos, but also stoke ethical concerns | 0 | 7 | 25-06-2026 |